GALNT3 and breast cancer: Further studies are necessary to verify possible GALNT3/T6 redundancies in other cancer types, and especially in breast cancer, where GALNT6 has displayed quite similar functions in mediating aberrant O-glycosylation [14], as found by us for GALNT3 in EOC [8].